OptimizeRx Launches ‘Digital Healthcare’ Webinar Series
10 März 2020 - 1:45PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies and payers, will host
three free webinars this week covering a range of topics around
using digital health technology to improve patient care and
engagement.
Session 1: “CDC Coronavirus
Alerts at the Point-of-Care: The Power of EHR Platform
Communications”This session will focus on OptimizeRx’s latest
integration of CDC Coronavirus alerts into its digital health
information network.Date: Tuesday, March
10Time: 11:30 am ET
Session 2: “Improving Adherence
Via Interactive Messaging”This session will focus on the barriers
to successful therapy adherence, including treatment affordability,
confusing therapy regimens, unexpected side effects, and more. It
will address how to overcome the barriers to successful therapy
adherence and engage patients throughout their healthcare
journey.Date: Wednesday, March
11Time: 1:30 pm ET
Session 3: “Technology
Interoperability Throughout the Care Journey”This session will
provide a behind-the-scenes view into how six independent and
dynamic health technologies help support a 40-year-old patient who
has been diagnosed with colon cancer. It will demonstrate how the
patient’s medical team is able to seamlessly exchange valuable
clinical data and create a comprehensive care plan for the best
overall outcome.Date: Thursday, March
12Time: 11:30 am ET (Time subject to change.
Please check webinar website for latest schedule.)
The webinar sessions are free and open to anyone
in the industry, and will provide an opportunity to engage directly
with OptimizeRx executive team.
Register today at
www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar
sessions, contact media relations at (754) 245-7070 or
malejandra@optimizerx.com.
About OptimizeRxOptimizeRx®
(NASDAQ: OPRX), a digital health company, connects pharmaceutical
companies to patients and providers, offering greater
affordability, adherence and brand awareness at the point-of-care.
As the nation’s largest digital platform connecting life sciences
to the point-of-care, OptimizeRx provides a direct channel for
pharma companies, payers, medtech, and medical associations to
communicate with healthcare providers right within their workflow
and also directly to patients.
The cloud-based solution supports patient
adherence to medications and better healthcare outcomes with
real-time access to financial assistance, prior authorization,
education and critical clinical information. OptimizeRx provides
more than half of the ambulatory patient market with access to
these benefits through leading EHR platforms like Allscripts,
Amazing Charts and Quest, and directly via its mobile
communications platform and digital therapeutics SaaS platform.
For more information, follow the company on
Twitter, LinkedIn or visit www.OptimizeRx.com.
Important Cautions Regarding Forward
Looking StatementsThis press release contains
forward-looking statements within the definition of Section 27A of
the Securities Act of 1933, as amended, and such as in section 21E
of the Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker,
CFOTel (248) 651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira
Alejandra, Media Relations ManagerTel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact Ron
Both, CMATel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024